In an article in the research journal PLoS Biology, Dr. Sam A. Deadwyler and his associates propose that CX717 would particularly benefit individuals affected by extended work hours or night shifts.
To test this possibility, they taught monkeys to perform a “delayed-match-to-sample task,” in which they were presented with a single image on a computer screen, then would use a cursor to identify that image in a group of several different images.
During normal alert conditions, performance accuracy of the animals was improved from an average of 75 percent to 90 percent after an injection of CX717. The drug also shortened response times, suggesting that “CX717 also facilitated attentional processes related to speed of responding on successful trials.”
When the monkeys were subjected 30-36 hours of sleep deprivation, average performance accuracy dropped to 63 percent, which was restored to 84 percent after CX717 treatment.
Man, I could have used some of that before . . .